American International Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-55,983
Closed -$180K 51
2024
Q1
$180K Sell
55,983
-481
-0.9% -$1.86K ﹤0.01% 2215
2023
Q4
$277K Sell
56,464
-228
-0.4% -$1.04K ﹤0.01% 1995
2023
Q3
$309K Buy
56,692
+2,016
+4% +$13.3K ﹤0.01% 1876
2023
Q2
$367K Buy
54,676
+866
+2% +$6.44K ﹤0.01% 1839
2023
Q1
$475K Buy
53,810
+1,071
+2% +$9.44K ﹤0.01% 1626
2022
Q4
$403K Sell
52,739
-191
-0.4% -$1.49K ﹤0.01% 1720
2022
Q3
$377K Buy
52,930
+747
+1% +$7.04K ﹤0.01% 1753
2022
Q2
$422K Buy
52,183
+50,218
+2,556% +$442K ﹤0.01% 1720
2022
Q1
$27K Sell
1,965
-2
-0.1% -$31 ﹤0.01% 2992
2021
Q4
$55K Sell
1,967
-69
-3% -$2.12K ﹤0.01% 2931
2021
Q3
$69K Sell
2,036
-161
-7% -$5.82K ﹤0.01% 2919
2021
Q2
$90 Buy
2,197
+488
+29% +$19K ﹤0.01% 2901
2021
Q1
$69 Sell
1,709
-205
-11% -$11.1K ﹤0.01% 2881
2020
Q4
$113 Sell
1,914
-80
-4% -$4.13K ﹤0.01% 2591
2020
Q3
$97K Buy
1,994
+48
+2% +$2.02K ﹤0.01% 2553
2020
Q2
$94K Buy
1,946
+554
+40% +$20.2K ﹤0.01% 2569
2020
Q1
$39K Buy
1,392
+1,044
+300% +$29.1K ﹤0.01% 2771
2019
Q4
$10K Sell
348
-14
-4% -$402 ﹤0.01% 3063
2019
Q3
$11K Buy
+362
New +$14.8K ﹤0.01% 3066

Other funds holding ADPT

American International Group's ADPT Position: Q2 2024 in Review

American International Group sold out of Adaptive Biotechnologies (ADPT) in Q2 2024, closing a stake of 55,983 shares — an estimated $180K sold.

American International Group first reported a position in ADPT in Q3 2019 and held it in 19 quarters. The position peaked at $475K in Q1 2023. 176 funds tracked by Wall St. Rank hold ADPT as of Q2 2024.

  • American International Group reported no remaining Adaptive Biotechnologies position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 55,983 Adaptive Biotechnologies shares in Q2 2024, an estimated $180K.
  • American International Group first reported a position in Adaptive Biotechnologies in Q3 2019 and held it in 19 quarters.
  • American International Group's Adaptive Biotechnologies position peaked at $475K in Q1 2023.
  • 176 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.